These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Search MEDLINE/PubMed
Title: Differentiation between uniform and non-uniform motor nerve conduction slowing. Author: Busch V, Schulte-Mattler WJ. Journal: Clin Neurophysiol; 2010 Jun; 121(6):890-4. PubMed ID: 20227911. Abstract: OBJECTIVE: Demyelination may cause a uniform reduction of the conduction velocity of all fibres of a peripheral nerve segment, or may affect only certain nerve fibres in a non-uniform way while sparing others. This study was done to improve the detection of non-uniform conduction slowing by using the high-frequency attenuation (HFA) method. METHODS: Nerve conduction data from patients with early inflammatory demyelinating neuropathy (non-uniform demyelination, n=20), hereditary neuropathy (uniform demyelination, n=9), motor neuron disease (axon loss, n=20), and from healthy control subjects (n=20) were analysed. RESULTS: HFA, compound muscle action potential (CMAP) amplitude decay, and F-wave chronodispersion correlated significantly. Among these variables both HFA and amplitude decay most sensitively identified non-uniform demyelination (35%). In the patients with uniform demyelination, the most frequent finding was a reduced nerve conduction velocity (NCV) (100%). The most specific marker of non-uniform demyelination was HFA. For uniform demyelination it was NCV. CONCLUSIONS: The pattern of correlations between the variables studied confirms that NCV and F-min are indicators of uniform conduction slowing. HFA, amplitude decay, and F-wave chronodispersion indicate non-uniform conduction slowing, for which HFA is both sensitive and specific. SIGNIFICANCE: The HFA method improves both the diagnostic sensitivity and specificity of nerve conduction studies in patients with non-uniform demyelination.[Abstract] [Full Text] [Related] [New Search]